[Tissue migration of neutrophil granulocytes in the course of antiproliferative treatment in Hodgkin's disease].
The ability of neutrophil granulocytes to mobilization in sterile inflammatory focus was studied in patients with Hodgkin's disease during treatment. Plastic chambers filled with patient's serum were used for this purpose. The migration ability of granulocytes in the group of patients was reduced already before beginning of treatment. It decreased even more 3 days after beginning of cytostatic treatment but on the 7th day the number of cells passing into the inflammatory exudate increased to values observed in healthy subjects. The observed changes were not correlated with fluctuations in the granulocyte count in the peripheral blood observed on the same days. It is suggested that the evaluation of migration ability of granulocytes to the inflammatory focus may provide better information about the defensive mechanisms of the organism than determination of the count of these cells in the peripheral blood.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002465:Cell Movement; D006689:Hodgkin Disease / Q000276:immunology*; D006801:Humans; D007958:Leukocyte Count; D009504:Neutrophils / Q000276:immunology*
D000970:Antineoplastic Agents
Migracja tkankowa granulocytów obojetnochłonnych w czasie leczenia antyproliferacyjnego ziarnicy złośliwej